Showing 5991-6000 of 23168 results for "".
Polycystic Ovary Disease
https://reachmd.com/programs/lipid-luminations/polycystic-ovary-disease/3180/Host Dr. Larry Kaskel welcomes Dr. Tara Dall, board-certified lipidologist at Advanced Lipidology in Wisconsin, to discuss chronic anovulation and hyperandrogenism, and its association with an increased risk of diabetes, metabolic syndrome and cardiac problems. She will also highight treatHypnosis in Clinical Medicine: Ready for Prime Time?
https://reachmd.com/programs/clinicians-roundtable/hypnosis-clinical-medicine-ready-prime-time/7425/Hypnosis, as a medical tool, doesn't enter the daily lexicon of clinical practice in most hospital settings. But for those familiar with its applications, hypnosis can be a versatile and powerfully effective therapeutic aid across the broad spectrum of psychiatric and somatic disease states. Will thUsing Calcium Scoring for Cardiovascular Risk Prediction
https://reachmd.com/programs/lipid-luminations/using-calcium-scoring-for-cardiovascular-risk-prediction/3902/Predicting the risk of heart attack is a tricky business. Dr. Carl Orringer, visiting associate professor of medicine at Case Western Reserve University School of Medicine and board-certified lipidologist who serves on the National Lipid Board of the National Lipid Association, talks withThe Latest Targets of Lipid Therapy
https://reachmd.com/programs/lipid-luminations/the-latest-targets-of-lipid-therapy/3182/Host Dr. Larry Kaskel welcomes Dr. Alan Brown, medical director of the Midwest Heart Disease Prevention Center in Naperville, Illinois, to discuss targets of lipid therapy. What are the calculated risk assessments for major cardiovascular events among patients with coronary disease, diabetes and othEating for Cardiovascular Health
https://reachmd.com/programs/lipid-luminations/eating-for-cardiovascular-health/4197/Mary Felando, clinical dietician at the Preventive and Rehabilitative Cardiac Center at Cedars-Sinai Medical Center in Los Angeles, joins host Dr. Larry Kaskel to discuss a heart healthy diet. How can you help your patients to regard meals as medicine? And what is the best 'medicine' for them?  Selenium in Chronic Illness
https://reachmd.com/programs/clinicians-roundtable/selenium-in-chronic-illness/3058/Selenium functions as a dietary antioxidant and may play a role in many chronic diseases. When should we consider selenium augmentation? Dr. Maria Boosalis joins host Dr. Leslie Lundt to discuss this exciting new area of nutritional research.Kundalini Yoga Meditation for Obsessive Compulsive Disorder (OCD)
https://reachmd.com/programs/clinicians-roundtable/kundalini-yoga-meditation-and-obsessive-compulsive-disorder-ocd/2716/OCD is considered one of the more treatment refractory psychiatric disorders. Might patients benefit from alternative therapy techniques? Host Dr. Leslie Lundt welcomes David Shannahoff-Khalsa to discuss his research using Kundalini Yoga Meditation to treat obsessive-compulsive disorder.Treatments for Cardiac Blood Vessel Inflammation In the Works
https://reachmd.com/programs/clinicians-roundtable/treatments-for-cardiac-blood-vessel-inflammation-in-the-works/3659/Why aren't there medications to treat atherosclerosis or, more specifically, the underlying chronic inflammation of the blood vessel walls associated with this condition? Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals, tells the Chicago Tribune's Bruce Japsen about the coming medicatioCholesterol Management in Children
https://reachmd.com/programs/lipid-luminations/cholesterol-management-in-children/3624/Host Dr. Larry Kaskel welcomes Dr. Don Wilson, professor and chair of pediatrics at the Texas A&M Health Sciences Center College of Medicine, to offer his counsel on the latest guidelines for pediatric cholesterol management. Why was this the time to revise previous recommendations? How do riskSpecial Report: Prescribing Statins for High-Risk Children
https://reachmd.com/programs/clinicians-roundtable/special-report-prescribing-statins-for-high-risk-children/3357/It's the leading cause of death and morbidity in American adults, but the cardiovascular disease process may begin in childhood. A new clinical report from the American Academy of Pediatrics (AAP) recommends some children as young as age 8 should receive pharmacologic treatment for dyslipidemia. The